astrazeneca
In Conversation with Alison Fragale
55:20
astrazeneca
Procurement at AstraZeneca in Lisbon
1:59
astrazeneca
High throughput screening at The DISC: a new era of drug discovery
4:32
astrazeneca
Full Year and Q4 2024 Results
1:05
astrazeneca
Cell therapy uncovered: advancing cell therapy in the clinic
1:28
astrazeneca
Cell therapy uncovered: advancing armoured CAR-Ts for solid tumours
1:19
astrazeneca
Cell therapy uncovered: pioneering TCR-Ts to target neoantigens in cancer treatment
1:20
astrazeneca
Cell therapy uncovered: overcoming manufacturing hurdles
1:15
astrazeneca
Cell therapy uncovered: a novel rapid manufacturing process
1:23
astrazeneca
Our ambition in cell therapy
3:03
astrazeneca
Harnessing the Power of Cell Therapy in Medicine
1:13
astrazeneca
AstraZeneca Postdoc Case Study: Data Science
4:24
astrazeneca
Oncology Biometrics
3:40
astrazeneca
Postdoc Case Study: Publication success
3:54
astrazeneca
Employee Resource Groups TH!NK
1:24
astrazeneca
Meet the TH!NK Employee Resource Groups and Understand the Impact This has on our Workplace
1:06
astrazeneca
AstraZeneca Barcelona, Great Place to Work, Great Place to Be
0:47
astrazeneca
AstraZeneca’s Young Health Programme Fellows at One Young World Summit 2024
1:29
astrazeneca
Lung Cancer, Stigma and Me: A patient story from the US
6:46
astrazeneca
Lung Cancer, Stigma and Me: A patient story from Chile
6:05
astrazeneca
Postdocs in Industry at AstraZeneca
5:31
astrazeneca
What makes a difference to our health
1:19
astrazeneca
The European Network on Climate & Health Education
1:47
astrazeneca
Stories Of Impact In Health Equity
29:34
astrazeneca
Robust and Durable Immune Response: Virus-Like Particle Vaccines
1:38
astrazeneca
Unlocking scientific discovery with collaboration
5:16
astrazeneca
What if cancer could be outsmarted, or maybe even cured?
1:29
astrazeneca
Oncology Cell Therapy: engineering innovative CAR-T cells
0:54
astrazeneca
H1 and Q2 2024 Financial Results
0:54
astrazeneca
The use of wearables in heart failure clinical trials
2:35
astrazeneca
Uniting for Uterine Cancer Awareness Month
20:29
astrazeneca
The Believers – Our next generation of leaders focused on climate action, equity & health resilience
2:45
astrazeneca
The Believers – The importance of youth engagement to build a healthier future (Elishia, UK)
1:01
astrazeneca
The Believers – Delivering greener, more equitable healthcare (Mohamed, Egypt)
1:00
astrazeneca
The Believers – Taking climate action and working in harmony with nature (Kate, UK)
0:57
astrazeneca
The Believers – Improving health system sustainability with digital innovation (Hiroyoshi, Japan)
0:57
astrazeneca
The Believers – Health system resilience and equity (Talita, Brazil)
0:54
astrazeneca
How do TCR-Ts differ from CAR-T cell therapies?
1:09
astrazeneca
Personalised Medicine Makes a Difference in Lung Cancer Diagnosis
2:56
astrazeneca
The next chapter for Healthy Heart Africa
2:36
astrazeneca
Oncology R&D strategy - attacking cancer from multiple angles
1:50
astrazeneca
AstraZeneca sets ambition to deliver $80 billion annual by 2030
0:31
astrazeneca
Women in leadership
6:44
astrazeneca
The challenges women face in the work place
8:31
astrazeneca
Career advice for women in the workplace
6:35
astrazeneca
Patients and experts call for action on World Asthma Day 2024
2:28
astrazeneca
Susan Galbraith: Driving innovation in cancer research
7:59
astrazeneca
BioPharmaceuticals Medical: Transforming Care
3:55
astrazeneca
Research collaboration to advance innovative solutions for patients with neurological diseases
2:56
astrazeneca
Inspiring futures: impact of STEM on women and girls
2:00
astrazeneca
AstraZeneca Performance and Recognition - CatAlyZe
0:17
astrazeneca
AstraZeneca Barcelona, Great Place to Work, Great Place to Be
0:47
astrazeneca
Full Year and Q4 2023 Results
1:03
astrazeneca
CoSolve 2023 announces collaboration with the Moss group
2:25
astrazeneca
Discover a culture of lifelong learning at AstraZeneca
1:27
astrazeneca
Living with Transthyretin Amyloidosis (ATTR)
3:46
astrazeneca
Trailblazing science: bispecific antibodies & immune cell engagers
1:10
astrazeneca
Better understanding cell therapies: The DIAL framework
0:52
astrazeneca
How T-cell engagers work for better cancer detection and treatment
0:55
astrazeneca
Bispecific Antibodies: Generating a Stronger Response Against Cancer
1:03
astrazeneca
COP28: AstraZeneca putting health at the heart of the climate crisis
1:44
astrazeneca
Empowering young leaders in the climate-health nexus
4:22
astrazeneca
Oncology evolution: Value assessment to keep pace with science
4:46
astrazeneca
A.Catalyst Network - Igniting innovation for a healthier world
2:09
astrazeneca
Functional genomics – Uncovering links between genes and disease using CRISPR
1:48
astrazeneca
Collaborative laboratory exploring functional genomics announced
1:44
astrazeneca
Advancing health systems decarbonisation ahead of COP28
4:01
astrazeneca
Cancer Care Africa
3:30
astrazeneca
Engineering a new CAR-T for solid tumours
1:41
astrazeneca
Young Health Programme Impact Fellows inspire positive change at One Young World Summit 2023
2:24
astrazeneca
The Climate and Us: Can medicine be made more sustainably?
7:15
astrazeneca
Girls Belong Here 2023 – A celebration of the power and potential of girls and young women
2:33
astrazeneca
Expanding access to clean heat and power to decarbonise the manufacture medicines
1:45
astrazeneca
Speak Up for COPD
4:22
astrazeneca
Celebrating global milestones in the Young Health Programme
2:58
astrazeneca
Our commitment to advancing CVRM treatment
2:06
astrazeneca
H1 and Q2 2023 Results
0:48
astrazeneca
Unlocking the potential of data & AI driven drug discovery and development
1:00
astrazeneca
Bronchiectasis, targeting infections to transform care
2:24
astrazeneca
Severe viral lung infections and ARDS, causes and effects
2:13
astrazeneca
Severe viral lung infections and ARDS, following the science
1:43
astrazeneca
Modelling chronic kidney disease using organoids
1:17
astrazeneca
Bronchiectasis, the unknown respiratory disease
2:31
astrazeneca
AZ Forest: committed to support biodiversity and human health
2:36
astrazeneca
Antibody drug conjugates: science and imagination linked by purpose
1:01
astrazeneca
Kate’s story
3:43
astrazeneca
Lean digital technologies to support our smart factories.
2:54
astrazeneca
Fostering a culture of lifelong learning
2:54
astrazeneca
Top tips for applying to AstraZeneca’s R&D Postdoc Challenge
4:18
astrazeneca
Detecting Cancer Earlier with Circulating Tumour DNA (ctDNA)
0:59
astrazeneca
Living with lupus: Jeanette’s story
3:50
astrazeneca
Explore our locations across North America
3:41
astrazeneca
Developing next-generation oligonucleotide therapeutics
6:54
astrazeneca
Computational Pathology: revolutionising cancer therapies and diagnostics
1:15
astrazeneca
Your treatment options after a Lung Cancer diagnosis
7:29
astrazeneca
How we’re inspiring change by embracing our differences
4:26
astrazeneca
Your Lung Cancer healthcare team
4:31
astrazeneca
Next steps after a Lung Cancer diagnosis
2:16
astrazeneca
Support after a Lung Cancer diagnosis
5:42
astrazeneca
Potential side effects
2:44